SentinelOne (S) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

PTC Therapeutics (PTCT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Bio-Techne faces significant macro and policy headwinds, including reduced academic research funding, China risks, and U.S.

Discover the Coal India Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a ...

Discover the HDFC Bank Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a ...